ABSTRACT
Objective D-dimer, ferritin, and fibrinogen parameters in COVID-19 patients are essential, particularly in inpatients and intensive care unit patients. It is vital to know the changes that occur due to the biological structure of the person than the disease effect in these tests in order to manage the fatal disease better.
Method Blood samples were taken on the first, third, and fifth days from 30 healthy volunteers, 15 of whom were smokers, 15 were non-smokers, and D-dimer, ferritin, and fibrinogen tests were studied with repeated measurements. After the data processed for normality and homogeneity and removing extreme values, CVA, CVI, CVG, CVT, RCV, II, I%, B%, TE% values were calculated via a full nested ANOVA design, according to Callum G, Fraser, and EFLM.
Results CVI and CVG values of D-dimer were calculated as 49.07% and 40.69% for all individuals, 49.26% and 27.71% for smokers, 48.80% and 51.67% for non-smokers, respectively. In terms of fibrinogen, the same analyzes for all individuals were calculated as 11.18% and 10.62%, 3.25% and 20.17% for smokers, 9.11% and 6.79% for non-smokers, respectively. The same analyzes for ferritin were calculated as 23.74% and 63.31% for all individuals, 34.98% and 35.24% for smokers, 30.53% and 74.87% for non-smokers, respectively.
Conclusion Changes in D-dimer measurements every other day in healthy individuals can be observed depending on the biological characteristics of the individuals, and the population-based reference interval may be insufficient for clinical evaluation. Each individual should be evaluated within himself/herself. When evaluating the results of ferritin and fibrinogen in non-smoking individuals, it should be taken into account that significant differences may occur between individuals. Besides, it should be kept in mind that there may be significant changes due to biological variation in the repeated measurements of ferritin every other day.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Amasya University Ethics committee gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
e-mail: cerrahemin{at}gmail.com
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
https://docs.google.com/spreadsheets/d/1nX71i-EG5bxk9eUDs0UAf1Dp23aqGxo9xtVInsAswXw/edit?usp=sharing
